{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:49:19Z","timestamp":1787021359774,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1245\/s10434-025-18792-7","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:38:48Z","timestamp":1764092328000},"page":"6691-6699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0923-153X","authenticated-orcid":false,"given":"Edmund K.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Kalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Ariyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Sue","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus J.","family":"Busam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Panageas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Coit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"3","key":"18792_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","volume":"78","author":"KG Paulson","year":"2018","unstructured":"Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457-463.e452.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"18792_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1245\/s10434-012-2779-3","volume":"20","author":"JA Santamaria-Barria","year":"2013","unstructured":"Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, Dias-Santagata D, Cusack JC Jr. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol. 2013;20(4):1365\u201373.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"18792_CR3","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","volume":"23","author":"PJ Allen","year":"2005","unstructured":"Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23(10):2300\u20139.","journal-title":"J Clin Oncol."},{"issue":"1","key":"18792_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","volume":"37","author":"J Albores-Saavedra","year":"2010","unstructured":"Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20\u20137.","journal-title":"J Cutan Pathol."},{"issue":"4","key":"18792_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejca.2010.11.002","volume":"47","author":"BA Reichgelt","year":"2011","unstructured":"Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993\u20132007. Eur J Cancer. 2011;47(4):579\u201385.","journal-title":"Eur J Cancer."},{"issue":"4","key":"18792_CR6","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/annonc\/mdr318","volume":"23","author":"T Jouary","year":"2012","unstructured":"Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol. 2012;23(4):1074\u201380.","journal-title":"Ann Oncol."},{"issue":"5","key":"18792_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","volume":"63","author":"BD Lemos","year":"2010","unstructured":"Lemos BD, Storer BE, Iyer JG, et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63(5):751\u201361.","journal-title":"J Am Acad Dermatol."},{"key":"18792_CR8","unstructured":"Bordeaux J, Nghiem P, Aasi SZ, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Merkel Cell Carcinoma. 2025; https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mcc.pdf. Accessed May 15, 2025."},{"issue":"2","key":"18792_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jaad.2020.07.065","volume":"84","author":"N Singh","year":"2021","unstructured":"Singh N, Alexander NA, Lachance K, et al. Clinical benefit of baseline imaging in Merkel cell carcinoma: analysis of 584 patients. J Am Acad Dermatol. 2021;84(2):330\u20139.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"18792_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jaad.2012.08.042","volume":"68","author":"EB Hawryluk","year":"2013","unstructured":"Hawryluk EB, O\u2019Regan KN, Sheehy N, et al. Positron emission tomography\/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber\/Brigham and Women\u2019s Cancer Center. J Am Acad Dermatol. 2013;68(4):592\u20139.","journal-title":"J Am Acad Dermatol."},{"issue":"9","key":"18792_CR11","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1245\/s10434-011-1662-y","volume":"18","author":"RC Fields","year":"2011","unstructured":"Fields RC, Busam KJ, Chou JF, et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol. 2011;18(9):2529\u201337.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"18792_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.suronc.2017.10.005","volume":"27","author":"JR Sims","year":"2018","unstructured":"Sims JR, Grotz TE, Pockaj BA, et al. Sentinel lymph node biopsy in Merkel cell carcinoma: the Mayo Clinic experience of 150 patients. Surg Oncol. 2018;27(1):11\u20137.","journal-title":"Surg Oncol."},{"issue":"3","key":"18792_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/PAP.0b013e3181a12f5a","volume":"16","author":"MP Pulitzer","year":"2009","unstructured":"Pulitzer MP, Amin BD, Busam KJ. Merkel cell carcinoma: review. Adv Anat Pathol. 2009;16(3):135\u201344.","journal-title":"Adv Anat Pathol."},{"issue":"43","key":"18792_CR14","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Software. 2019;4(43):1686.","journal-title":"J Open Source Software."},{"issue":"1","key":"18792_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg DD, Whiting K, Curry M, Lavery JA, Larmarange J. Reproducible summary tables with the gtsummary package. R J. 2021;13(1):570\u201380.","journal-title":"R J."},{"key":"18792_CR16","doi-asserted-by":"crossref","unstructured":"Sjoberg DD, Fei T. tidycmprsk: competing risks estimation. R package version 0.2. 0. 2022;19.","DOI":"10.32614\/CRAN.package.tidycmprsk"},{"key":"18792_CR17","doi-asserted-by":"crossref","unstructured":"Sjoberg DD, Baillie M, Haesendonckx S, Treis T. ggsurvfit: Flexible time-to-event figures. R package version. 0.3: 0. 2023.","DOI":"10.32614\/CRAN.package.ggsurvfit"},{"issue":"12","key":"18792_CR18","doi-asserted-by":"publisher","first-page":"7261","DOI":"10.1245\/s10434-022-12174-z","volume":"29","author":"RJ Straker 3rd","year":"2022","unstructured":"Straker RJ 3rd, Sharon CE, Fraker DL, Karakousis GC, Miura JT. Contemporary analysis of sentinel lymph node biopsy performance among patients with clinically localized Merkel cell carcinoma. Ann Surg Oncol. 2022;29(12):7261\u20134.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"18792_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/annonc\/mdw035","volume":"27","author":"A Servy","year":"2016","unstructured":"Servy A, Maubec E, Sugier PE, et al. Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy. Ann Oncol. 2016;27(5):914\u20139.","journal-title":"Ann Oncol."},{"issue":"2","key":"18792_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/bjd.14240","volume":"174","author":"DA Gunaratne","year":"2016","unstructured":"Gunaratne DA, Howle JR, Veness MJ. Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases. Br J Dermatol. 2016;174(2):273\u201381.","journal-title":"Br J Dermatol."},{"issue":"2","key":"18792_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jaad.2019.03.027","volume":"81","author":"RRZ Conic","year":"2019","unstructured":"Conic RRZ, Ko J, Saridakis S, Damiani G, Funchain P, Vidimos A, Gastman BR. Sentinel lymph node biopsy in Merkel cell carcinoma: predictors of sentinel lymph node positivity and association with overall survival. J Am Acad Dermatol. 2019;81(2):364\u201372.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"18792_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archderm.142.6.685","volume":"142","author":"SG Gupta","year":"2006","unstructured":"Gupta SG, Wang LC, Pe\u00f1as PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142(6):685\u201390.","journal-title":"Arch Dermatol."},{"issue":"7","key":"18792_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599\u2013609.","journal-title":"N Engl J Med."},{"issue":"11","key":"18792_CR24","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","volume":"23","author":"KL Harms","year":"2016","unstructured":"Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, Wong SL. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol. 2016;23(11):3564\u201371.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"18792_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jaad.2023.11.020","volume":"90","author":"AM McEvoy","year":"2024","unstructured":"McEvoy AM, Hippe DS, Lachance K, et al. Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: a multivariable model and web-based calculator. J Am Acad Dermatol. 2024;90(3):569\u201376.","journal-title":"J Am Acad Dermatol."},{"key":"18792_CR26","doi-asserted-by":"crossref","unstructured":"Zijlker LP, Watts F, Wong T, et al. Prognostic significance of sentinel node tumor burden in Merkel cell carcinoma. EJC Skin Cancer. 2025\/01\/01\/ 2025;3:100728.","DOI":"10.1016\/j.ejcskn.2025.100728"},{"issue":"10404","key":"18792_CR27","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0140-6736(23)00769-9","volume":"402","author":"JC Becker","year":"2023","unstructured":"Becker JC, Ugurel S, Leiter U, et al. Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. Lancet. 2023;402(10404):798\u2013808.","journal-title":"Lancet."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18792-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18792-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18792-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:51:29Z","timestamp":1780761089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18792-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["18792"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18792-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EKB has received research funding via the institution from SkylineDx and QBiotics Group; provided consulting\/advisory services for QBiotics Group; CEA has provided consulting\/advisory services for Iovance Biotherapeutics, Merck & Co., and Merck KgaA. CAB has provided consulting\/advisory services for Regeneron. CMK has received research funding via the institution from Amgen, curadev, IDRx, Inhibrx, Merck, Regeneron, and Servier; provided consulting\/advisory services for Daiichi Sankyo; and has a spouse employed by Daiichi Sankyo. No other authors have relationships with outside entities to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}